Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact on +44 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
I want to take this opportunity to say “thank you” very much for all your help and support with my job searching. The professionalism that Zenopa showed me was also brilliant.
Suraj , 2014

Kimberly-Clark sees year-on-year growth in first quarter

27 April 2010 00:00 in Pharmacy Supplier News


Kimberly-Clark has published its financial report for the first quarter of 2010, reporting a 7.6 per cent year-on-year increase in its net sales.

The company's sales for the three-month period grew to $4.8 billion (3.1 billion pounds), with the company's healthcare, personal care and consumer products divisions all seeing net sales growth.

In addition, the firm's acquisitions of I-Flow Corporation and Jackson Safety last year were also cited as having contributed to this quarter's improved sales performance.

Thomas Falk, chairman and chief executive officer, described the figures as a "solid start to the year".

He said: "We strengthened our brands by launching a number of innovations in the first quarter and by significantly increasing strategic marketing spending."

Last month, Kimberly-Clark revealed plans to launch a number of consumer health and hygiene products over the coming year, including new Poise and Depend incontinence offerings and a number of new additions to the Kotex feminine care brand.

Other news stories from 27/04/2010

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd